Intellectual Property Transfer and MTA Compliance Support

The contract encompasses the legal and technical transfer of intellectual property associated with the transferrin receptor under a Materials Transfer Agreement, requiring comprehensive documentation and secure packaging of all relevant data to ensure full compliance with National Institutes of Health intellectual property policies. The work must be executed with precision to meet federal standards for IP handoff, including chain-of-custody records, data integrity protocols, and adherence to NIH-specific regulatory frameworks governing the movement of biological materials and associated proprietary information. The performance location is designated as Bethesda, Maryland, with a strict response deadline of July 31, 2026, and the opportunity is classified as a subcontract under NAICS code 541611, reflecting its alignment with scientific research and development services. The contracting entity is the National Institutes of Health, operating through the Department of Health and Human Services, and all activities must be coordinated to satisfy federal compliance requirements without deviation. Although no specific point of contact is provided, the submission must demonstrate proven expertise in IP transfer procedures, materials handling, and NIH policy alignment to qualify for award.